We apply science-based discovery strategies in the process of identifying new materials, enabling the development of innovative ingredients.
We establish a multi-layered validation system from basic cellular research to human application, ensuring the reliability and reproducibility of our materials.
Moving beyond a single-ingredient development approach, we integrate complex material design, efficacy validation, and enhanced delivery efficiency to maximize the completeness of high-performance new material development.
Selection of high-performing functional materials through initial screening Precise comparison by material functionality and characteristics Optimized formulation to maximize functional synergy Securing patents related to new materials
Establishment of a full-cycle efficacy validation system covering in vitro, ex vivo, and clinical stages
Initial functional validation at the cellular and tissue levels
Preclinical safety secured through toxicity testing
Selection of materials with proven real-use efficacy for clinical application
Continuous data reliability validation through specialized institutions
Utilization of bio-derived intercellular signaling carriers
Enhanced delivery of active ingredients through nanoparticle-based systems
Overcoming limitations in conventional safety and production yield through microbial EVs
Protection of the physical and chemical properties of active ingredients
Based on the production of eco-friendly and safe materials, we enhance both functional production efficiency and bioavailability by integrating strain discovery, medium design, fermentation process optimization, and low-molecular-weight conversion technology.
By controlling fermentation environments optimized for the characteristics of lactic acid bacteria strains, we ensure the production efficiency and quality consistency of functional substances while maximizing absorption in the body by controlling the structural properties of polymeric materials.
This integrated fermentation strategy serves as a core foundation for securing both the industrial productivity and practical efficacy of functional materials.
Continuous discovery and utilization of high-functionality new strains
Functional validation of strains based on precise analysis
Establishment of a strain and functionality library
Development of a large-scale data-based strain screening system
Design of proprietary microbial culture media with growth factors and minerals
Establishment of optimal culture conditions based on statistical experimental design
Maximization of functional substance production and growth efficiency
Ensuring quality consistency and reproducibility during mass production
Low-molecular-weight conversion of polymeric materials through fermentation
Enhancement of mobility and absorption efficiency in the body
Improved in vivo diffusion rate through increased molecular mobility
Increased delivery to target sites and improved practical tissue absorption
We integrate process standardization and scale-up for bio-based ingredients.
We systematically manage every stage, from ingredient specification setting and process establishment to quality validation, pilot testing, and mass production optimization.
We transform research-level technologies into stable industrial production processes while ensuring consistent quality and production efficiency.
Qualitative and quantitative analysis of key active ingredients
Establishment of ingredient specifications and standards
Selection of marker compounds and establishment of a management system
Ensuring batch-to-batch quality consistency
Quality control based on ingredient stability and reproducibility
Establishment of SOPs for the entire process
Quantification and standardization of process conditions and operating procedures
Securing process reproducibility and strengthening operational stability
Optimization of process structures to improve production efficiency
Analysis of physicochemical properties and establishment of quality standards
Performance of analytical validation
Ensuring data accuracy and reliability
Establishment of a quality system capable of responding to global regulatory approvals
Operation of a continuous quality monitoring and improvement system
Application of laboratory processes to pilot-scale expansion
Evaluation of the effects of process variables
Analysis of changes in yield and quality characteristics
Validation of reproducibility and stability according to scale changes
Application and Scale-up of Pilot Processes for Mass Production Environments
Establishment of Control Strategies for Key Process Variables
Securing Batch-to-Batch Quality Consistency and Minimizing Variability
Process Optimization to Improve Production Efficiency and Yield
Establishment of an Operational System for Stable Commercial Production
We develop customized functional ingredients, brands, and products based on a science-backed material platform.
We strengthen market competitiveness by building a technology storyline that connects branding with R&D according to the characteristics of the target market.
Based on our proprietary one-stop system, we comprehensively manage the full development cycle of bio products, considering efficacy, delivery, and safety.
Function-Oriented Design and Structuring of Key Ingredients
Expansion and Application of Minexin-Based Materials
Discovery of New Bio Materials and Verification of Applicability
Development of Customized Ingredients According to Purpose
Planning of Technology-Based Product Concepts
Positioning Design Based on Target Markets and Application Areas
Product Lineup and Structure Design
Establishment of a Connection Structure Between Brand Direction and Technology
Function-Based Formulation Design
Development of Formulations Considering Delivery Efficiency and Stability
Production Application Based on Process Standardization
Establishment of a Scalable Structure from Pilot Production to Mass Production
We move beyond a single-ingredient-centered approach and select promising candidates from materials of diverse origins through initial screening.
We precisely compare the functionality of carefully selected materials by characteristics, based on bioactivity indicators, concentration-dependent responses, and cellular response patterns.
To maximize synergistic effects between materials, we realize optimal functionality through formulation design that considers gene/protein expression mechanisms, action pathways, and stability.
Through a composite material design strategy, we secure patents and apply them to products, complementing the limitations of individual materials and maximizing efficacy.
We have established a full-cycle verification system ranging from in vitro and ex vivo testing to clinical stages, going beyond cellular-level validation and setting pharmaceutical-level evaluation standards.
In the initial stage, we evaluate material efficacy at the cellular and tissue levels, including anti-glycation, antioxidant, brightening, anti-inflammatory, and scalp health effects, while securing preclinical safety through toxicity testing.
We then use only materials whose efficacy has been proven in real-use environments through human application testing.
This secures the reliability of functionality based on continuous application data from specialized partner institutions, including clinics, Korean medicine clinics, healthcare centers, and aesthetic shops.
Our developed materials are effectively protected, delivered, and absorbed through probiotic-derived extracellular vesicles (EVs).
EVs are nano-sized structures generated for intercellular communication, offering excellent mobility in the body and stable passage through tissue microenvironments.
We apply next-generation microbial EVs that overcome the infection risks of animal-cell EVs and the low-yield limitations of plant-cell EVs, securing both safety and production efficiency while maximizing delivery performance.
Nano-sized carriers (50 ~ 1,000 nm): Excellent tissue mobility through the skin barrier and follicle pathways (50,000 nm), maximizing absorption efficiency
Fermentation-based microbial EVs: Minimization of zoonotic infection risk and improvement of production yield
Phospholipid bilayer structure: Protection of cargo and securing stability during the delivery process
Our high-functionality products are produced by independently discovering new strains with strong potential for functional expression.
We select highly functional strains based on bioactivity evaluation, metabolite analysis, and growth characteristic assessment, and precisely screen strains according to functional expression characteristics and metabolic pathways.
By continuously securing new strains from diverse origins, we have built a genomic-functional data library and established a systematic screening environment.
We design proprietary media reflecting microbial growth factors and mineral components to maximize strain metabolic activity and the production efficiency of functional substances.
Culture conditions, including pH, temperature, time, and media composition, are quantitatively optimized based on Design of Experiments (DoE), improving both fermentation efficiency and production yield.
This process design serves as the foundation for securing consistent quality and reproducibility even in mass production environments.
Our research can maximize the action mechanisms of high-molecular-weight functional materials that have limitations in in-body mobility and absorption efficiency.
By utilizing fermentation and process control technologies to reduce high-molecular structures into lower-molecular forms, we improve molecular mobility and increase delivery efficiency within the skin and tissues.
Low-molecular-weight materials increase diffusion speed in the body and improve target-site reachability, contributing to enhanced practical absorption of functional ingredients.
This structure-control-based approach serves as a core technology for improving the bioavailability of functional materials.
We perform qualitative and quantitative analysis of key active ingredients and establish raw material specifications based on the results.
By selecting and systematically managing marker compounds, we minimize batch-to-batch quality variation and secure the stability and reproducibility of raw materials, maintaining overall quality standards.
We systematically establish Standard Operating Procedures (SOPs) for all processes and quantify process conditions and work procedures to secure reproducibility and operational stability.
Based on this, we improve production efficiency and minimize variation between processes.
We establish quality standards through physicochemical property analysis and test method validation, while securing the accuracy and reliability of analytical data.
We also establish a quality management system that meets global regulatory standards, enabling continuous quality monitoring and improvement.
We scale up processes established at the laboratory level to pilot scale and comprehensively verify process variables, yield, and quality variability.
Through this, we evaluate the feasibility of transition to commercial production while securing both process stability and economic efficiency.
We apply pilot-verified processes to mass production environments and enhance process control strategies and quality management standards to secure batch-to-batch consistency.
Through this, we maximize production efficiency and establish a stable commercial production system.
Bio-based new materials are designed around functionality verified through the full-cycle process from cellular testing to clinical evaluation.
Using our independently developed Minexin™ as the central matrix, we structure key active ingredients and provide a platform that considers both stability and biocompatibility.
We develop customized ingredients by precisely controlling physical properties, delivery performance, stability, and functionality according to the intended application.
Beyond functional ingredient development, we continuously expand scalability and applicability through an ingredient platform-centered approach.
Product development begins with concept design based on technical evidence, rather than simple functional implementation.
We define product positioning by reflecting the environmental and physiological characteristics of the target market, and design suitable functional structures and storylines.
The product lineup is structured around mechanisms rather than single functions, maximizing effects at each stage of use.
We strengthen market competitiveness by connecting brand direction and R&D strategy into a consistent technology story.
Our products are designed with formulations that consider the maintenance of bioactivity and delivery efficiency of functional ingredients, securing both physical stability and usability.
We develop products with optimized active ingredient performance by precisely controlling carrier structure, particle size, and interfacial properties.
Based on process standardization, we have established a highly reproducible manufacturing process that can scale lab-scale formulations up to pilot scale.
Our proprietary one-stop system enables product planning through development, supporting the development of bio-technology-based cosmetics, functional foods, and pharmaceuticals.
© 2026 PHARMOLOGY All right reserved
